Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 2.13p
   
  • Change Today:
      0.000p
  • 52 Week High: 7.76
  • 52 Week Low: 1.59
  • Currency: UK Pounds
  • Shares Issued: 333.40m
  • Volume: 153,381
  • Market Cap: £7.08m
  • RiskGrade: 328

Latest Deals

Traded Action Notifier PriceAmountValue
10-Aug-22 Placing Tim Franklin 5.00p 400,000 £20,000.00
10-Aug-22 Placing Lisa Baderoon 5.00p 400,000 £20,000.00
10-Aug-22 Placing Timothy Paul McCarthy 5.00p 1,200,000 £60,000.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
10-Aug-22 Placing Timothy Paul McCarthy 5.00p 1,200,000 £60,000.00
10-Aug-22 Placing Lisa Baderoon 5.00p 400,000 £20,000.00
10-Aug-22 Placing Tim Franklin 5.00p 400,000 £20,000.00

Director Shareholdings

Notifier Holding Value*
Dimitri Dimitriou 3,528,969 £74,991
Timothy Paul McCarthy 1,488,462 £31,630
Lisa Baderoon 583,963 £12,409
Tim Franklin 525,000 £11,156
Franco Di Muzio 60,950 £1,295
Stephane Robert George Mery 2,259 £48

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 36,307,599 £771,536
Luca & Associates AG 22,000,000 £467,500
Invesco Ltd 17,872,341 £379,787
Aviva Investors Global 11,285,180 £239,810
Alora Pharmaceuticals LLC 10,909,091 £231,818
M&G Investments 7,600,000 £161,500
Prudential plc 7,600,000 £161,500
Capital Income Builder 4,870,367 £103,495
Dr R Zimmer 4,551,553 £96,720
Odey Asset Management 3,433,319 £72,958
Rhone Trustees (Switzerland) SA 3,386,000 £71,952
Pictet Overseas Trust Corporation Limited 3,287,500 £69,859

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 2.13p
Change Today 0.000p
% Change 0.00 %
52 Week High 7.76
52 Week Low 1.59
Volume 153,381
Shares Issued 333.40m
Market Cap £7.08m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
75.80% above the market average75.80% above the market average75.80% above the market average75.80% above the market average75.80% above the market average
83.05% above the sector average83.05% above the sector average83.05% above the sector average83.05% above the sector average83.05% above the sector average
Price Trend
87.47% below the market average87.47% below the market average87.47% below the market average87.47% below the market average87.47% below the market average
58.73% below the sector average58.73% below the sector average58.73% below the sector average58.73% below the sector average58.73% below the sector average
Income Not Available
Growth
40.82% below the market average40.82% below the market average40.82% below the market average40.82% below the market average40.82% below the market average
61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average61.9% below the sector average

Immupharma Dividends

No dividends found

Trades for 31-Mar-2023

Time Volume / Share Price
12:14 18,467 @ 2.12p
11:39 100 @ 1.93p
11:19 59,839 @ 2.12p
10:22 50,000 @ 2.04p
09:52 20,500 @ 1.92p

Immupharma Key Personnel

CEO Dimitri Dimitriou

Top of Page